Physician

Elizabeth R. Plimack, M.D.

According to 2025 Medicare claims, Elizabeth Plimack, M.D. (NPI: 1477647659) practices hematopoietic cell transplantation and cellular therapy in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is TEMPLE FACULTY PRACTICE PLAN, INC (NPI: 1417430166; TIN: 831002191) and primary practice location at 19111-2434.

Plimack's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 123 traditional Medicare patients, billed 325 HCPCS/CPT codes, and received $32,343 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 656 prescription claims across 91 beneficiaries totaling $2,840,685 in drug costs, led by Lenvima (Lenvatinib Mesylate). 2021 DME data shows 11 claims. Open Payments data shows 25 records totaling $880,758. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $40,770 and ending at $32,343. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,515,220 to $2,840,685. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	166	480	$40,770
2016	166	455	$39,483
2017	180	508	$44,046
2018	180	526	$45,892
2019	164	555	$42,431
2020	134	450	$32,446
2021	136	376	$32,159
2022	133	470	$45,041
2023	120	327	$30,143
2024	123	325	$32,343

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	64	441	$1,515,220
2016	64	401	$1,652,104
2017	75	480	$2,445,067
2018	73	557	$3,389,920
2019	82	580	$4,046,269
2020	72	601	$3,544,241
2021	72	563	$3,194,693
2022	73	574	$3,535,307
2023	69	415	$1,952,892
2024	91	656	$2,840,685

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	24	$838
2019	N/R	75	$3,826
2020	N/R	67	$5,585
2021	N/R	11	$1,090
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	17	17	$139
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	11	11	$108
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	75	157	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	82	121	$86

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenvima	Lenvatinib Mesylate	23	690	$842,054
Xtandi	Enzalutamide	48	1,440	$475,607
Inlyta	Axitinib	23	690	$407,625
Abiraterone Acetate	Abiraterone Acetate	187	5,610	$315,690
Votrient	Pazopanib Hcl	38	1,140	$211,454

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$19,733	Eisai Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	10	$861,025	American Oncologic Hospial
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Elizabeth R. Plimack, M.D.?

Tedicare shows public-source Medicare data for Elizabeth R. Plimack, M.D. (NPI 1477647659), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Elizabeth R. Plimack, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Elizabeth R. Plimack, M.D.?

Elizabeth R. Plimack, M.D. is linked to TEMPLE FACULTY PRACTICE PLAN, INC (billing NPI 1417430166) in the available physician profile data.

Does Elizabeth R. Plimack, M.D. have Open Payments data?

Elizabeth R. Plimack, M.D. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.